MEGAN BURKE: Open Payments
NPI 1417559071 · LONG BRANCH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 12 payments from 9 companies in 2025. Trend: 2023 $604 · 2024 $372 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Boston Scientific Corporation | 2 | $51 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| BridgeBio Pharma, Inc. | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: BENLYSTA, LEQVIO, WATCHMAN FLX, LifeVest, VERQUVO, ONPATTRO, Attruby, FARXIGA.
Industry payments across NJ — which companies pay providers there.
